These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4376515)

  • 1. Cellular immunity against tumor-associated antigens in humans: lymphocyte stimulation and skin reaction.
    Vánky R; Klein E; Stjernswärd J; Nilsonne U
    Int J Cancer; 1974 Aug; 14(2):277-88. PubMed ID: 4376515
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system.
    Kumar S; Taylor G; Steward JK; Waghe MA; Morris-Jones P
    Int J Cancer; 1973 Jul; 12(1):194-205. PubMed ID: 4364270
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular and humoral immunity to different types of human neoplasms.
    Hellström I; Hellström KE; Pierce GE; Yang JP
    Nature; 1968 Dec; 220(5174):1352-4. PubMed ID: 4302696
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunology of melanoma].
    Vanwijck R; Bernheim JL; Lejeune FJ
    Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
    [No Abstract]   [Full Text] [Related]  

  • 6. Host immune response to virus-induced tumors. Some recent concepts.
    Aoki T; Chieco-Bianchi L; Plata EJ; Sendo F; Hollis VW; Kudo T
    Prog Exp Tumor Res; 1974; 19():23-36. PubMed ID: 4373781
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-mediated and humoral immunity studies of murine and hamster sarcoma virus-induced producer and non-producer tumors in syngeneic animals.
    McCoy JL; Ting RC; McCoy NT; Reisher JI; Chan SP; Law LW
    Int J Cancer; 1974 May; 13(5):731-41. PubMed ID: 4367343
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of host immunity in human neoplasia. II. Discussion.
    Br J Cancer Suppl; 1973 Aug; 1():162-9. PubMed ID: 4374227
    [No Abstract]   [Full Text] [Related]  

  • 9. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.
    Brooks WH; Netsky MG; Normansell DE; Horwitz DA
    J Exp Med; 1972 Dec; 136(6):1631-47. PubMed ID: 4345108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific cellular cytotoxicity to human sarcomas: evidence for a cell-mediated host immune response to a common sarcoma cell-surface antigen.
    Cohen AM; Ketcham AS; Morton DL
    J Natl Cancer Inst; 1973 Mar; 50(3):585-9. PubMed ID: 4513520
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.
    Hellström KE; Hellström I
    Adv Immunol; 1974; 18():209-77. PubMed ID: 4597622
    [No Abstract]   [Full Text] [Related]  

  • 12. [Demonstration, by means of allogenic antigens, of an antitumoral immunity with cellular mediation in humans].
    Febvre H; Moutte A; Constans JP
    C R Acad Hebd Seances Acad Sci D; 1972 Nov; 275(19):2191-4. PubMed ID: 4346143
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocyte stimulation by autologous tumor cells in the presence of serum from the same patient or from healthy donors.
    Vánky F; Klein E; Stjernswärd J; Trempe G
    Int J Cancer; 1975 Nov; 16(5):850-60. PubMed ID: 1058840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-associated antigens and tumour-host interactions.
    Baldwin RW
    Proc R Soc Med; 1971 Oct; 64(10):1039-42. PubMed ID: 4335921
    [No Abstract]   [Full Text] [Related]  

  • 15. Host immunity to growing sarcomas: tumor-specific serum inhibition of tumor-specific cellular immunity.
    Cohen AM
    Cancer; 1973 Jan; 31(1):81-9. PubMed ID: 4509387
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for immune reactivity against neoplasms.
    McKhann CF; Jagarlamoody SM
    Transplant Rev; 1971; 7():55-77. PubMed ID: 4112673
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte-mediated immune responses in neoplasia.
    Pilch YH; Golub SH
    Am J Clin Pathol; 1974 Aug; 62(2):184-211. PubMed ID: 4602086
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.
    Heppner GH; Stolbach L; Byrne M; Cummings FJ; McDonough E; Calabresi P
    Int J Cancer; 1973 Mar; 11(2):245-60. PubMed ID: 4790694
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonspecific lymphocyte cytotoxicity in patients with malignant melanoma, renal cell carcinoma, and sarcomas, and in nontumor patients.
    Bukowski RM; Barna B; Deodhar SD; Hewlett JS
    Cancer; 1976 Nov; 38(5):1962-7. PubMed ID: 991109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the tumor-associated reactivity of blood lymphocytes and tumor-draining lymph node cells in sarcoma patients.
    Vánky F; Stjernswärd J; Nilsonne U; Sundblad
    J Natl Cancer Inst; 1973 Jul; 51(1):17-24. PubMed ID: 4720872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.